Akero Therapeutics Inc sell Marianka
Start price
15.09.22
/
30%
€26.40
Target price
15.09.23
€8.00
Performance (%)
-1.52%
End price
17.09.22
€26.00
Summary
This prediction ended on 17.09.22 with a price of €26.00. With a performance of -1.52%, the SELL prediction by Marianka was trending in the right direction. Marianka has 30% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | -6.457% | -6.457% | -55.476% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to Marianka what are the pros and cons of Akero Therapeutics Inc for the foreseeable future?
Pros
Revenue growth >5% per year expected
Fair valuation
Capable Management
Good culture
Leading role in innovation
Some uniques
Sustainability is important
Cons
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
Junk rating
Little Investments for future growth
High risks in the balance sheet
ROE lower than 10% per year
very negative Cash Flow expected
High challenges to pay loans and raise capital
Dependend from some customers or products
Growths slower than the competition
high free float
High risks for its business
Below average Marketposition
Very high cyclical dependencies
Unknown brand
Outdated or very high risk business model